초붕괴제 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 제제/제형별, 치료 영역별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Superdisintegrants Market size was valued at USD 567.85 Million in 2024 and is poised to grow from USD 613.28 Million in 2025 to USD 1135.14 Million by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).

The global superdisintegrants market is integral to the pharmaceutical industry, focusing on excipient polymers that enhance tablet disintegration upon contact with saliva, thereby facilitating rapid drug release in oral solid dosage forms. The sector is driven by the increasing demand for fast-disintegrating tablets, which significantly improve patient compliance among diverse demographics, including pediatric and geriatric populations. Innovations such as croscarmellose sodium and sodium starch glycolate have expanded formulation possibilities, while the emphasis on patient-centric delivery bolsters market growth globally, particularly in emerging economies. The surge in personalized medicine drives formulators to incorporate advanced superdisintegrants in intricate dosage forms, prompting manufacturers to explore reliable polymers capable of rapid dissolution. Additionally, AI-driven formulation automation streamlines product development, enhances consistency, and accelerates market entry, positioning the sector for significant growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Superdisintegrants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Superdisintegrants Market Segments Analysis

Global superdisintegrants market is segmented by product type, formulation / dosage form, therapeutic area, end user and region. Based on product type, the market is segmented into Croscarmellose Sodium, Crospovidone (Polyplasdone), Sodium Starch Glycolate (SSG), Ion Exchange Resins, Modified Cellulose, Natural Superdisintegrants and Others. Based on formulation / dosage form, the market is segmented into Tablets & Capsules, Orally Disintegrating Tablets (ODTs), Mouth-Dissolving Films (MDFs) and Granules & Pellets. Based on therapeutic area, the market is segmented into Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Oncology and Other Therapeutic Areas. Based on end user, the market is segmented into Pharmaceutical Manufacturers, CDMOs & CROs and Nutraceutical Manufacturers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Superdisintegrants Market

The growing demand for orally disintegrating medications is prompting pharmaceutical companies to incorporate superdisintegrants into tablet formulations, thereby improving patient adherence and therapeutic outcomes. These superdisintegrants facilitate rapid disintegration when they come into contact with saliva, making dosage forms more convenient, particularly for elderly and pediatric patients. To meet this demand, manufacturers are increasingly focused on researching and developing advanced superdisintegrant technologies, which not only drive market growth through innovative products but also expand therapeutic applications. Furthermore, the enhanced dissolution characteristics offered by these agents align with regulatory standards for bioequivalence, promoting their adoption in both generic and branded drug development.

Restraints in the Global Superdisintegrants Market

The Global Superdisintegrants market faces challenges due to intricate regulatory frameworks surrounding excipient safety and quality, which can significantly extend product approval timelines. This extended process generates uncertainty for manufacturers aiming to bring new superdisintegrants to the market. The requirements for comprehensive toxicological assessments, stability studies, and thorough compliance documentation lead to increased development costs and resource demands. As a result, companies may delay investments in innovative disintegrant technologies or opt for established ingredients that already have regulatory approval. This trend stifles market growth and restricts the introduction of cutting-edge solutions in pharmaceutical offerings, while also complicating supply chain planning due to uncertain approval timelines.

Market Trends of the Global Superdisintegrants Market

The Global Superdisintegrants market is witnessing a notable trend towards sustainability, as pharmaceutical manufacturers focus on eco-friendly superdisintegrant alternatives. This shift emphasizes the use of biodegradable and plant-derived polymers, which not only minimize environmental impact but also uphold essential performance criteria. By integrating sustainable practices into their excipient portfolios, formulators are reshaping supplier relationships to prioritize responsible sourcing. With increasing consumer awareness and demand for green-label products, companies are leveraging these sustainable materials to enhance differentiation, reinforce regulatory compliance, and bolster brand credibility. Overall, this trend reflects a broader commitment to environmentally conscious manufacturing within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Superdisintegrants Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Croscarmellose Sodium
• Crospovidone (Polyplasdone)
• Sodium Starch Glycolate (SSG)
• Ion Exchange Resins
• Modified Cellulose
• Natural Superdisintegrants
• Others

Global Superdisintegrants Market Size by Formulation / Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets & Capsules
• Orally Disintegrating Tablets (ODTs)
• Mouth-Dissolving Films (MDFs)
• Granules & Pellets

Global Superdisintegrants Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Cardiovascular
• Central Nervous System (CNS)
• Gastrointestinal
• Oncology
• Other Therapeutic Areas

Global Superdisintegrants Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Manufacturers
• CDMOs & CROs
• Nutraceutical Manufacturers

Global Superdisintegrants Market Size & CAGR (2026-2033)

• North America (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • US
  • Canada
• Europe (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Formulation / Dosage Form, Therapeutic Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ashland Global Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Soda Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow Inc. (The Dow Chemical Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JRS Pharma (J. Rettenmaier & Sohne)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corporation (IFF Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LyondellBasell Industries N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (Berry Global)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich (Merck KGaA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Roth GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMC Biopharmaceuticals A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avacta Group PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wyeth Pharmaceuticals (Pfizer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hanmi Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinofi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healtec Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck Sharp & Dohme)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations